TrialScope is part of Informa Pharma Intelligence, a division of Informa Business Intelligence, Inc. (IBI). IBI is a wholly-owned subsidiary of Informa PLC.

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Let’s work together to improve clinical trial transparency — and health around the world.

Keeping up with clinical trial transparency is no easy feat. Government regulations constantly change. Knowing what compliance data needs to be disclosed, when, and how, isn’t always clear. Finding suitable recruiting trials can be extremely challenging for patients and their families. And properly disclosing results to study participants, researchers, and the general public? That can have its own set of hurdles.

TrialScope is the answer. Through extensive industry expertise and a proven technology platform, we help sponsors like you navigate the journey toward transparency and compliance with complete confidence.

Work with our solutions to optimize the efficiency of your disclosure activities, foster a more informed, engaged patient community, and connect the dots for accelerated study recruitment.

One platform. Unlimited potential. Let’s get started.

Partner with us.
And let’s work together to realize
a new standard in complete
clinical trial transparency.

Meet the team transforming trial transparency.

With a wealth of experience that spans technology, healthcare, life sciences and pharmaceuticals, the TrialScope leadership team is uniquely qualified to lead the charge toward greater trial transparency. Get to know the people behind the movement.

Jeff is a serial healthcare entrepreneur with over 20 years of pharmaceutical experience. Before taking over as TrialScope CEO in 2018, Jeff served on the Company’s Board of Directors for more than two years.

Prior to TrialScope, Jeff was the founder of two healthcare technology companies, HeroLinx and Verilogue. HeroLinx was an online crowdsourcing platform for accelerating clinical trial awareness and patient recruiting. Verilogue, which was acquired by Publicis (PUB:FP), is the global software leader in the capture and linguistic analysis of physician-patient exam room dialogues.

Jeff serves on the Board of Directors for three rapidly growing venture-backed companies: Analytical Wizards, Signallamp Health and Ripple Science. He also previously served on the Board of Directors for iContracts (acquired by RLDatix) and he remains an investor/advisor to other early-stage companies.

Jeff holds a BS in Economics from the Wharton School at the University of Pennsylvania, and is the co-author of a method and system patent for analyzing the effectiveness of marketing strategies.

Matt has nearly 20 years of experience in financial operations and management in various organizations ranging from fortune 500 companies to small venture-backed organizations.

Most recently he served as the COO for Verilogue, a venture-backed tech-enabled research company, with a successful exit in 2013.  

Matt started his career at KPMG spending nearly 5 years performing financial audits on mid-sized public companies.  These companies covered a wide range of industries including software, manufacturing, retail, and hi-tech development.  Matt then moved on to serve 7 years as the Vice President of Finance and Land Development for Pulte Homes, the largest national homebuilder in America, overseeing all finance, legal, HR, and land issues for the Delaware Valley Area.  Matt served as the CFO of STRATIS IoT, a venture-backed software startup, overseeing a Series A capital raise and the implementation of various software solutions including, Pardot and automated HR tools.  Matt was also the Vice President of Finance at Bohler Engineering overseeing the implementation of a new ERP system covering 13 offices in 7 states.

Matt received a bachelor’s degree in accounting from The Pennsylvania State University and received his CPA license from the state of Pennsylvania (active 2003-2006).

Thomas has more than 17 years of experience with performance and content management solutions, specializing in applications for life sciences such as clinical trial disclosure, structured product labelling and submissions management and has been on the PharmaCM team since 2007.

Prior to the acquisition of PharmaCM by TrialScope, Thomas served as the General Manager of PharmaCM at Deloitte and as the Director of PharmaCM Product Management at Intrasphere Technologies. Before joining Intrasphere, Thomas worked in leadership, client-facing positions for Revelwood Inc. and Shepherd Systems, focused on performance management solutions.

Chris has nearly 15 years of experience in commercial leadership positions in various organizations ranging in size from startup to fortune 500 companies.

Most recently he served as the CRO for Signals Analytics, a Sequoia Capital backed Artificial Intelligence SaaS platform, successfully doubling revenue during his tenure.

Chris also has held high-profile leadership positions at Clarivate Analytics, Thomson Reuters, Deloitte and Informa. A frequent speaker and trainer, Chris is passionate about innovating the sales process to help organizations achieve commercial success.

He holds a Bachelor of Science in Communications from the State University of New York.

Dave has more than 20 years of experience in the Life Sciences industry where he has focused on building successful client services organizations as well as developing process oriented operations. He has successfully contributed to the growth and expansion of several companies through a customer first focus.

Dave’s Life Sciences background includes roles such as Vice President and General Manager of ArisGlobal’s eClinical Business Unit as well as holding a senior level position at eResearchTechnologies, Inc., where he served as the General Manager & Senior Vice President of the eClinical Group. Prior to joining TrialScope, Dave also worked for several early-stage companies where he owned P&L responsibility as a business unit head as well as serving as the President & CEO for a publicly traded company. He has consistently contributed to the development of key areas of the business, including but not limited to, sales and marketing, professional services, product development, customer support, and operations. Dave graduated from Pennsylvania State University with a B.S. in Accounting and a Minor in Economics.

An award-winning B2B marketer and creative strategist, Naor brings to TrialScope his experience leading high-performance teams at global growth companies spanning healthcare technology, life sciences, marketing research, and workspace design.

He believes that great marketing starts with a clear understanding of customer passions and pain points, and that helping solve everyday business challenges via thought leadership is the pathway to building long term value, demand and brand preference.

Naor previously led marketing at remarkable healthcare technology companies including SmartLinx, CRF Health (now Signant Health), and Verilogue.

He holds a B.S. in Marketing from the Rutgers Business School at Rutgers University, and a Marketing Strategy Certification from the Cornell University Samuel Curtis Johnson Graduate School of Management.

Francine is responsible for helping TrialScope customers meet and exceed current disclosure expectations globally, giving them the tools they need to meet all the requirements in this evolving industry.

Francine also dedicates her time building relationships with external stakeholders – including sponsors, investigators, regulators, and transparency and patient advocates – to help align the goals and expectations of these groups, as well as help identify more consistent ways sponsors can meet industry standards. Prior to her role as Vice President of Global Transparency, Francine served as Director of Product Management at TrialScope. She also serves as Chair of the Drug Information Association (DIA) Clinical Trial Disclosure Community.

Mike is a software developer and entrepreneur with over 8 years of experience developing solutions for patients.

Mike was an Associate Director at the Michael J. Fox Foundation for Parkinson’s Research where he oversaw the development of Fox Trial Finder and Fox Insight, two platforms to help the Parkinson’s community connect with clinical trials and track their disease over time. Mike went on to join Epion Health as Lead Developer where he and his team developed a solution to simplify the check-in process for patients and their medical providers. Mike founded Clinical Trial Connect in 2015 to bring clinical trial matching capabilities to more patient advocacy groups and scaled the platform to support over 20 national patient advocacy groups. Clinical Trial Connect was acquired by TrialScope in October 2019 and Mike looks forward to continuing to promote clinical trial awareness and helping patients in their journey.

Dispatches from the frontlines of trial transparency.

There’s never a dull moment at TrialScope. As we work to establish — and support — a new standard of clinical trial transparency, you’ll find the latest updates here, from product releases to events, partnerships, presentations and more. Stay in the loop!

Be a part of the clinical trial
transparency revolution.

Because we’re always innovating, we’re always on the lookout for imaginative, customer-
centric, roll-up-your-sleeves people to join the team. Explore our current career

TrialScope Support

Our team is just a call or email away.

Our customer support team is here to assist you, troubleshoot and answer any questions you may have. Let us know how we can help through the TrialScope Community portal below.